CAAS
CEMI

Capital Asset Advisory Services’s Chembio diagnostics, Inc. CEMI Stock Holding History

Capital Asset Advisory Services’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed – – 1674
2020
Q4 		$0 Buy
+100
New +$516 ﹤0.01% 1628

Other funds holding CEMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Capital Asset Advisory Services's CEMI Position: Q1 2021 in Review

Capital Asset Advisory Services sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2021, closing a stake of 100 shares.

Capital Asset Advisory Services first reported a position in CEMI in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 72 funds tracked by Wall St. Rank hold CEMI as of Q1 2021.

  • Capital Asset Advisory Services reported no remaining Chembio diagnostics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Capital Asset Advisory Services sold 100 Chembio diagnostics, Inc. shares in Q1 2021.
  • Capital Asset Advisory Services first reported a position in Chembio diagnostics, Inc. in Q4 2020 and held it in 1 quarter.
  • Capital Asset Advisory Services's Chembio diagnostics, Inc. position peaked at $0 in Q4 2020.
  • 72 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2021.

Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.